更好的药物的蓝图:纳米医学的结构革命
Chad A Mirkin1,2,3,4,5, Robert Langer6, Milan Mrksich1,2,3,7
1Department of Chemistry, Northwestern University, Evanston, Illinois 60208, United States.
ACS nano
|May 13, 2025
概括
结构纳米药物通过精确的设计提供了更高的疗效. 进一步定义这些纳米医学架构将改善患者的安全性,制造和治疗结果.
科学领域:
- 纳米医学是一种纳米医学.
- 药物运输 药物运输 药物运输
- 生物技术是生物技术.
背景情况:
- 结构纳米医药利用精确的架构来改善治疗组件的传递.
- 多价值和多功能设计提供了诸如定向交付和增强目标参与等优势.
- 目前的纳米医学精度有所变化,影响了优化,制造和监管过程.
研究的目的:
- 突出结构纳米药在小分子,核酸和生物学的潜力.
- 在纳米医药开发中倡导更大的结构定义.
- 推进纳米医学结构-功能关系的理解.
主要方法:
- 对结构性纳米药物的当前研究进行审查和综合.
- 对精确定义的纳米医学架构所提供的优势的分析.
- 讨论纳米医学精度的挑战和机遇.
主要成果:
- 结构纳米药物展示了转型潜力,以mRNA COVID-19疫苗为例.
- 纳米医学结构的可变性需要专注于精确的架构控制.
- 确定最佳结构是理解结构-功能关系的关键.
结论:
- 提高纳米药物的结构精度对于简化开发和监管至关重要.
- 对结构功能关系的进一步研究将导致更安全,更有效的治疗方法.
- 这项工作旨在激发该领域的创新和患者受益的纳米医学解决方案.
相关概念视频
Structure-Activity Relationships and Drug Design
461
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
461
Factors Affecting Dissolution: Particle Size and Effective Surface Area
647
Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are...
647
Drug Discovery: Overview
7.2K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.2K
Drug Biotransformation: Overview
2.2K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
2.2K
Drug Administration and Therapy Phases: Overview
391
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
391


